C
Cyclerion Therapeutics, Inc. (CYCN)
NCM – Real Time Price. Currency in USD
3.38
+0.21 (6.62%)
At close: Jun 26, 2026, 4:00 PM EDT
3.31
-0.07 (-2.07%)
After-hours: Jun 26, 2026, 7:32 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
3.38
+0.21 (6.62%)
At close: Jun 26, 2026, 4:00 PM EDT
3.31
-0.07 (-2.07%)
After-hours: Jun 26, 2026, 7:32 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.80 | 6.05 | 9.0 | |
| Quick ratio | 1.80 | 5.63 | 9.0 | |
| Debt to Equity | 0.00 | 0.30 | 10 | |
| Debt to Assets | 0.00 | 1.04 | 10 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 297K | N/A | 2M | 2M | 2M |
| Gross Profit | 232K | N/A | N/A | N/A | N/A |
| Operating Income | -19M | -10M | -4M | -5M | -7M |
| Net Income | -44M | -21M | -3M | -4M | -5M |
| EBITDA | -18M | -10M | -4M | -5M | -7M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | N/A | 1.0 |
| Next quarter | N/A | N/A | 1.0 |
| Current year | -100 | 10.45 | 4.0 |
| Next year | N/A | 17.5 | 5.0 |
| Weighted average score | 2.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -99.99 | -297.61 | N/A | 21.34 | 3.3 |
| Y/Y | -99.99 | -122.31 | N/A | -28.3 | 1.0 |
| 3y average | 300.9 | 40.79 | N/A | 50.27 | 7.8 |
| 5y average | 176.39 | 34.13 | N/A | 38.06 | 7.8 |
| Weighted average score | 5.0 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Cash reserves $2.8M barely cover the upcoming debt maturities $0.0
Total current assets $3.1M exceed Total current liabilities $1.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$1.2M limits the company's ability to reinvest or pay down debt